513 related articles for article (PubMed ID: 30448334)
1. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
Kurova N; Timofeeva EV; Guiso N; Macina D
Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
[TBL] [Abstract][Full Text] [Related]
2. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
[TBL] [Abstract][Full Text] [Related]
3. Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
Noel G; Badmasti F; Nikbin VS; Zahraei SM; Madec Y; Tavel D; Aït-Ahmed M; Guiso N; Shahcheraghi F; Taieb F
PLoS One; 2020; 15(9):e0238398. PubMed ID: 32870922
[TBL] [Abstract][Full Text] [Related]
4. Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
Paradowska-Stankiewicz I; Rumik A; Bogusz J; Zbrzeźniak J; Rastawicki W; Śmietańska K; Vargas-Zambrano JC; Macina D
Vaccine; 2021 Oct; 39(41):6067-6073. PubMed ID: 34511302
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
[TBL] [Abstract][Full Text] [Related]
7. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
8. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
[TBL] [Abstract][Full Text] [Related]
9. [Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].
Seçkin H; Ormeci AR; Sandal G; Kaya S
Mikrobiyol Bul; 2013 Jul; 47(3):507-13. PubMed ID: 23971928
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
[TBL] [Abstract][Full Text] [Related]
11. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N
Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of pertussis in China: need to improve vaccination strategies.
Xu Y; Wang L; Xu J; Wang X; Wei C; Luo P; Ma X; Hou Q; Wang J
Hum Vaccin Immunother; 2014; 10(1):192-8. PubMed ID: 24018405
[TBL] [Abstract][Full Text] [Related]
13. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
Yeh SH; Mink CM
Drugs; 2006; 66(6):731-41. PubMed ID: 16706548
[TBL] [Abstract][Full Text] [Related]
14. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
Front Immunol; 2018; 9():51. PubMed ID: 29416544
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
16. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of pertussis antibodies in 6-17-year-old students in Ahvaz, south-west Islamic Republic of Iran.
Shamsizadeh A; Nikfar R; Yusefi H; Abbasi-Montazeri E; Cheraghian B
East Mediterr Health J; 2014 Oct; 20(10):623-6. PubMed ID: 25356693
[TBL] [Abstract][Full Text] [Related]
18. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.
Hallander HO; Andersson M; Gustafsson L; Ljungman M; Netterlid E
APMIS; 2009 Dec; 117(12):912-22. PubMed ID: 20078557
[TBL] [Abstract][Full Text] [Related]
20. Whooping cough, twenty years from acellular vaccines introduction.
Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
